A comprehensive view of Respiratory / Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Forestry & Timberland Market Intelligence Service.
European Commission approves Merck’s KEYTRUDA pembrolizumab plus chemotherapy as neoadjuvant treatment, then continued as monotherapy as adjuvant treatment, for resectable non-small cell lung cancer at high risk of recurrence in adults
Published:
March 28, 2024
by Business Wire
|
UNICEF delivers 254,000 Pfizer COVID-19 vaccine doses to Ukraine with support from GAVI; COVID-19, SARS and influenza have affected over 3.7 million Ukrainians since October 2023
Published:
March 28, 2024
by Interfax Ukraine Political News
|
Moderna announces Phase 3 success of next-gen COVID-19 vaccine, forthcoming flu combo vaccine, and progress in pivotal viral caccines set for 2024
Published:
March 28, 2024
by Industry Intelligence Inc.
|
US Patent Issued to AMOREPACIFIC on March 26 for "Composition for improving respiratory health continuously exposed to particulate matter atmosphere" (South Korean Inventors)
Published:
March 27, 2024
by U.S. Fed News
|
FTC files an amicus brief alleging that Teva improperly listed patents on its ProAir HFA asthma inhaler in the FDA Orange Book, blocking Amneal's approval for a generic version; the FTC is seeking a court judgement to make Teva retract the patents
Published:
March 25, 2024
by FiercePharma
|
Ask us about our Forestry & Timberland market view